MannKind Corporation

MannKind Corporation focuses on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes. The Company's lead product candidate, Afrezza, is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. Afrezza is a rapid-acting inhaled insulin therapy indicated to improve glycemic control in adults with diabetes. Taken at the start of a meal using a specially designed inhaler, Afrezza dissolves rapidly upon inhalation to the deep lung and delivers insulin quickly to the bloodstream.

Company Growth (employees)
Type
Public
HQ
Westlake Village, US
Founded
1991
Size (employees)
153 (est)
MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, US

Key People/Management at MannKind Corporation

Michael Castagna

Michael Castagna

Chief Executive Officer
Steven Binder

Steven Binder

Chief Financial Officer
Joseph Kocinsky

Joseph Kocinsky

Chief Technology Officer
Rose Alinaya

Rose Alinaya

Senior Vice President, Investor Relations and Treasury
David Thomson

David Thomson

Corporate Vice President, General Counsel and Corporate Secretary
Courtney Barton

Courtney Barton

VP, Chief Compliance and Privacy Officer
Patrick McCauley

Patrick McCauley

Chief Commercial Officer
Stuart Tross

Stuart Tross

Chief People Officer

MannKind Corporation Office Locations

MannKind Corporation has offices in Westlake Village and Danbury
Westlake Village, US (HQ)
301 30930 Russell Ranch Rd
Show all (2)

MannKind Corporation Financials and Metrics

MannKind Corporation Financials

MannKind Corporation's revenue was reported to be $174.8 m in FY, 2016
USD

Revenue (Q3, 2017)

2 m

Gross profit (Q3, 2017)

(6.2 m)

Gross profit margin (Q3, 2017), %

(304%)

Net income (Q3, 2017)

(32.9 m)

EBIT (Q3, 2017)

(28.2 m)

Market capitalization (22-Dec-2017)

252.3 m

Cash (30-Sep-2017)

20.1 m

EV

417.6 m
MannKind Corporation's current market capitalization is $252.3 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

174.8 m

Revenue growth, %

(99%)(100%)

Cost of goods sold

67.4 m17.1 m

Gross profit

157.6 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

162.4 m3 m2.2 m2 m

Cost of goods sold

1.9 m5.7 m8.1 m7.5 m3.7 m4.3 m2.5 m11.9 m8.3 m

Gross profit

(1.9 m)(5.7 m)(8.1 m)(7.5 m)(3.7 m)158 m461 k(9.8 m)(6.2 m)

Gross profit Margin, %

97%15%(452%)(304%)
USDFY, 2014FY, 2015FY, 2016

Cash

120.8 m59.1 m22.9 m

Accounts Receivable

50.4 m30.9 m

Prepaid Expenses

20.2 m4 m4.4 m

Inventories

9.7 m2.3 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

93.8 m35.8 m41.2 m172.5 m120.8 m107.2 m32.9 m27.7 m63.7 m35.5 m48 m43.4 m20.1 m

Accounts Receivable

4.3 m4.7 m1.7 m144 k3.1 m438 k1.3 m1.8 m

Prepaid Expenses

16.4 m14.1 m2.8 m1.4 m4.5 m3.5 m2.6 m3.1 m

Inventories

16.8 m19.8 m23.4 m2.9 m5.1 m3.7 m3.2 m3.1 m
USDFY, 2014FY, 2015FY, 2016

Net Income

(198.4 m)(368.4 m)125.7 m

Depreciation and Amortization

18.6 m13.3 m4.2 m

Accounts Receivable

(50.4 m)50.4 m(302 k)

Inventories

(9.7 m)13.5 m(2.3 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(50.8 m)(52.1 m)(73.4 m)(36.5 m)(30.7 m)(59.6 m)(91.4 m)(24.9 m)(54.8 m)71.7 m(16.3 m)(51.7 m)(84.5 m)

Depreciation and Amortization

3 m6.6 m10.1 m1 m2.1 m3.1 m908 k1.8 m2.7 m

Accounts Receivable

46.2 m45.7 m48.8 m(3.1 m)30.4 m29.5 m29.1 m

Inventories

26.4 m(10.1 m)(13.7 m)(2.9 m)(5.1 m)(1.4 m)(841 k)(798 k)
USDY, 2017

EV/EBIT

-14.8 x

EV/CFO

-12 x

Revenue/Employee

13.4 k

Financial Leverage

-0.2 x
Show all financial metrics

MannKind Corporation Operating Metrics

FY, 2014FY, 2015FY, 2016

Patents Issued

292330425

Patents Pending

230350250
Show all operating metrics

MannKind Corporation Market Value History

MannKind Corporation's Web-traffic and Trends

MannKind Corporation Online and Social Media Presence

MannKind Corporation Company Life and Culture

You may also be interested in